TrialX
Image

A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis

Study on colds and immune responses in bronchiectasis patients.

Recruiting
18-65 years
All
Phase N/A

Study Purpose: This research is looking into how the common cold virus affects people with bronchiectasis, a lung condition. It will see if it causes flare-ups and how the immune system responds compared to healthy individuals.

Eligibility: Adults aged 18 to 65 can join. We need people with bronchiectasis and healthy individuals. If you have any major health issues, are pregnant, or smoke, you might not be eligible.

Study Details: The study lasts 42 days (about 6 weeks). Participants will get a spray containing a cold virus in their nose. There will be a total of 11 visits, with some tests like blood tests, lung checks, and bronchoscopy (a test that checks inside your lungs). You'll need to keep a daily record of your symptoms.

  • Length of Study: 42 days with 11 visits.
  • Participation: Sprayed with a cold virus and monitored closely.
  • Exclusion: No smoking, pregnancy, or recent use of certain medications.

Note: This research takes place at St Mary's Hospital in London, UK.

Study details
    Bronchiectasis Adult
    Bronchiectasis With Acute Exacerbation
    Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa
    Viral Infection
    Rhinovirus Infection

NCT06931002

Imperial College London

23 January 2026

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.